Hernández D, Díaz F, Rufino M, Lorenzo V, Pérez T, Rodríguez A, De Bonis E, Losada M, González-Posada J M, Torres A
Nephrology Services, Hospital Universitario de Canarias, Tenerife, Spain.
J Am Soc Nephrol. 1998 Aug;9(8):1507-10. doi: 10.1681/ASN.V981507.
Stenosis of the subclavian vein (SVS) after cannulation occurs in 15 to 50% of chronic hemodialysis patients, and impedes the placement of an arteriovenous fistula in the ipsilateral arm. Its natural history and pathogenic mechanisms are not well established. This study examined 42 consecutive chronic renal failure patients (28 men and 14 women; 46+/-19 yr) in whom subclavian catheters had been placed as the initial vascular access for hemodialysis. All patients underwent sequential venography studies: at baseline (24 to 48 h after removal of the catheter) and 1, 3, and 6 mo thereafter. Venograms were considered abnormal when there was evidence of unequivocal strictures (more than 30% narrowing), with or without collateral circulation. At baseline, 52.4% (n=22) of patients showed stenotic vein lesions (n=19) or total thrombosis (n=3), and identical lesions were also observed after 1 mo. Surprisingly, 10 of 22 patients with initial SVS (45.4%) showed spontaneous recanalization of venous lesions in the venographies performed 3 mo after removal. The patients with normal baseline venograms (n=20) showed no change during follow-up. Patients with definitive stenosis at 6 mo (n=12) had a higher number of inserted catheters (1.58+/-0.6 versus 1.2+/-0.48; P < 0.05), longer time in place (49.08+/-32.2 versus 29.03+/-26.6 d; P < 0.05), and higher number of dialysis sessions (21+/-13.8 versus 12.4+/-11.4; P < 0.05) than those without SVS or with spontaneous recanalization of venous lesions during follow-up. Furthermore, a higher number of catheter-related infections were observed in patients with definitive SVS (66.6% versus 33.3%; P < 0.05). In summary, SVS is observed in more than half of patients 24 to 48 h after catheter removal and 1 mo later. Even when recanalization occurs in many cases, a definitive stenosis is seen in 28% of patients by the third month. Thus, the creation of an ipsilateral vascular access is possible provided that venography is normal at this time. Finally, mechanical factors and catheter-related infections are the major risk factors for the development of late SVS.
锁骨下静脉插管后狭窄(SVS)在15%至50%的慢性血液透析患者中出现,阻碍了同侧手臂动静脉内瘘的建立。其自然病程和发病机制尚未完全明确。本研究对42例连续性慢性肾衰竭患者(28例男性和14例女性;年龄46±19岁)进行了检查,这些患者均已置入锁骨下导管作为血液透析的初始血管通路。所有患者均接受了系列静脉造影检查:在基线时(拔除导管后24至48小时)以及此后1、3和6个月。当有明确狭窄(狭窄超过30%)的证据,无论有无侧支循环时,静脉造影被视为异常。在基线时,52.4%(n = 22)的患者出现静脉狭窄病变(n = 19)或完全血栓形成(n = 3),1个月后也观察到了相同的病变。令人惊讶的是,22例初始患有SVS的患者中有10例(45.4%)在拔除导管后3个月进行的静脉造影中显示静脉病变自发再通。基线静脉造影正常的患者(n = 20)在随访期间无变化。6个月时出现明确狭窄的患者(n = 12)与无SVS或随访期间静脉病变自发再通的患者相比,置入导管的数量更多(1.58±0.6比1.2±0.48;P < 0.05),留置时间更长(49.08±32.2比29.03±26.6天;P < 0.05),透析次数更多(21±13.8比12.4±11.4;P < 0.05)。此外,在出现明确SVS的患者中观察到更多与导管相关的感染(66.6%比33.3%;P < 0.05)。总之,在拔除导管后24至48小时以及1个月后,超过一半的患者出现SVS。即使在许多情况下发生再通,到第三个月时仍有28%的患者出现明确狭窄。因此,如果此时静脉造影正常,建立同侧血管通路是可行的。最后,机械因素和与导管相关的感染是晚期SVS发生的主要危险因素。